Prostate derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer

MLA

Ghadersohi, Ali, et al. Prostate Derived Ets Transcription Factor (PDEF) Is a Potential Prognostic Marker in Patients with Prostate Cancer. Jan. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8868729eb845734333fa2ae5a99a3673&authtype=sso&custid=ns315887.

APA

Ghadersohi, A., Sharma, S., Zhang, S., Azrak, R. G., Wilding, G. E., Manjili, M. H., & Li, F. (2011). Prostate derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.

Chicago

Ghadersohi, Ali, Satish Sharma, Shaozeng Zhang, Rami G. Azrak, Gregory E. Wilding, Masoud H. Manjili, and Fengzhi Li. 2011. “Prostate Derived Ets Transcription Factor (PDEF) Is a Potential Prognostic Marker in Patients with Prostate Cancer,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8868729eb845734333fa2ae5a99a3673&authtype=sso&custid=ns315887.